AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Aker BioMarine

Earnings Release Sep 25, 2023

3527_rns_2023-09-25_b00d3b6b-5242-4974-bdc9-fad7b8bf0707.html

Earnings Release

Open in Viewer

Opens in native device viewer

Successful launch of Superba Krill Oil in South Korea

Successful launch of Superba Krill Oil in South Korea

25 September 2023: Aker BioMarine, together with its South Korean partner, successfully reintroduced Superba sales in South Korea through a TV home shopping launch yesterday. Results came in at the TV channel’s target, with good levels of interest and momentum to enable the local partner to continue to build the launch marketing campaign as planned. The company will continue to work closely with its local partner to gradually rebuild the South Korean market in the coming weeks and months ahead.

Further information will be provided in company’s Q3 2023 report released on 1 November 07:00.

For further information, please contact

Christopher Robin Vinter, VP IR & Corporate Finance

Mobile: +47 911 60 820

Email: [email protected]

About Aker BioMarine

Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.